VIR BIOTECHNOLOGY Trademark
Trademark Overview
On Tuesday, July 23, 2024, a trademark application was filed for VIR BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the VIR BIOTECHNOLOGY trademark a serial number of 98661988. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, May 6, 2025. This trademark is owned by Vir Biotechnology, Inc.. The VIR BIOTECHNOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Antiviral pharmaceuticals; immunotherapy pharmaceuticals for the treatment of cancer, tumors, and immune system related diseases and disorders; antiviral pharmaceuticals for use in the treatment of infectious diseases and disorders and in the field of oncology
Research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines
General Information
| Serial Number | 98661988 |
| Word Mark | VIR BIOTECHNOLOGY |
| Filing Date | Tuesday, July 23, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of two ribbons. The lefthand ribbon starts at the center-top of the image, curves toward the center, bends away, and ends in the bottom-left corner. The smaller righthand ribbon starts near the right-top corner, curves toward the center, bends away before it meets the lefthand ribbon, and ends near the bottom-right. A circle appears above and between the two ribbons. The phrase "VIR BIOTECHNOLOGY" is to the right of the ribbons. |
| Goods and Services | Antiviral pharmaceuticals; immunotherapy pharmaceuticals for the treatment of cancer, tumors, and immune system related diseases and disorders; antiviral pharmaceuticals for use in the treatment of infectious diseases and disorders and in the field of oncology |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vir Biotechnology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94158 |
Trademark Events
| Event Date | Event Description |
| Tuesday, July 23, 2024 | NEW APPLICATION ENTERED |
| Monday, January 13, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 30, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 6, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, February 6, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, February 6, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 5, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 5, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, May 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
